Cannavative

In October 2026, Cannavative’s mix concentrated in Pre-Roll at 70.25% share with a month-over-month decline of 53.65% and a year-over-year drop of 69.41%, while Vapor Pens held 16.24% share with steeper shifts of -87.68% MoM and -94.01% YoY. Edible accounted for 7.29% share with a 43.90% MoM decrease and no year-over-year baseline, and Concentrates at 3.85% share fell 41.53% MoM and 80.20% YoY; Capsules, though only 2.38% share, rose 442.01% YoY but still declined 45.07% MoM. The brand’s average price fell 5.59% YoY to $15.94 as category price points ranged from $14.31 in Edible to $29.97 in Concentrates, and Pre-Roll pricing at $14.43 sat below the brand average. The pattern implies Cannavative is overexposed to a shrinking Pre-Roll base while the small but fast-growing Capsules line provides the only YoY expansion signal, suggesting a need to rebalance toward higher-margin or less volatile formats.

Within Nevada Pre-Rolls, Cannavative ranked 53rd, and with Pre-Roll at 70.25% of mix alongside a 69.41% YoY contraction, the brand’s core position is tethered to a category where its relative rank is low. The 94.01% YoY and 87.68% MoM declines in Vapor Pens indicate weakened traction in an adjacent inhalable, while the 442.01% YoY jump in Capsules against a 45.07% MoM pullback points to volatility rather than steady scale. Given the 5.59% YoY average price decrease and Pre-Roll pricing 9.5% below the brand average, the mix skews toward lower-price units, which implies Cannavative’s current positioning leans on price-accessible inhalables rather than differentiation in premium or resilient subsegments.